Triple

T6211324
Position Surface form Disambiguated ID Type / Status
Subject European Quarter of Strasbourg E138876 entity
Predicate hostsInstitution P186 FINISHED
Object Pharmacopoeia Secretariat of the Council of Europe E12899 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Pharmacopoeia Secretariat of the Council of Europe | Statement: [European Quarter of Strasbourg, hostsInstitution, Pharmacopoeia Secretariat of the Council of Europe]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Pharmacopoeia Secretariat of the Council of Europe
Context triple: [European Quarter of Strasbourg, hostsInstitution, Pharmacopoeia Secretariat of the Council of Europe]
  • A. European Pharmacopoeia
    The European Pharmacopoeia is a legally binding reference work that sets quality standards for medicines and their ingredients across member states of the Council of Europe.
  • B. Certificates of Suitability to the monographs of the European Pharmacopoeia
    Certificates of Suitability to the monographs of the European Pharmacopoeia are official documents issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM) confirming that a substance’s quality complies with the relevant European Pharmacopoeia monograph, thereby simplifying regulatory approval for medicines across Europe.
  • C. European Directorate for the Quality of Medicines & HealthCare chosen
    The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
  • D. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • E. European medicines regulatory authorities
    European medicines regulatory authorities are national and regional agencies in Europe responsible for evaluating, authorizing, and monitoring the safety, quality, and efficacy of medicinal products.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69c008ada364819096c9e92c74d639b5 completed March 22, 2026, 3:20 p.m.
NER Named-entity recognition batch_69c0628adccc8190b94f5c2c1d5d03f7 completed March 22, 2026, 9:43 p.m.
NED1 Entity disambiguation (via context triple) batch_69c16f57821c8190bd7a5f6bf286ab09 completed March 23, 2026, 4:50 p.m.
Created at: March 22, 2026, 4:21 p.m.